Herbalife Q3
This article was originally published in The Tan Sheet
Executive Summary
Net sales for the third quarter were up 18.8% over the prior-year period to $476.4 mil., largely attributable to revenue increases in the U.S. (up 24.7%) and Mexico (up 66%), Herbalife announces Nov. 8. New products launched during the quarter included a water-mixable version of the Formula 1 protein drink and a reformulated version of the Garden 7 phytonutrient supplement. The firm opened five stores in China, bringing its presence in that country to 33 stores in 20 provinces. Greater China accounted for 7.6% of worldwide sales, contributing $36.2 mil. during the quarter. The company expects net sales growth of 18%-20% during the fourth quarter...
You may also be interested in...
Noncompliance Issues In Mexico Lead To Decreased Growth For Herbalife
Herbalife announces Jan. 4 it lowered its 2007 sales growth expectations because of problems in Mexico, including noncompliance issues
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.